These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

34 related articles for article (PubMed ID: 16161928)

  • 1. Sarcoidosis presenting as tattoo changes in a patient undergoing treatment with interferon-alpha and ribavirin.
    Werchniak AE; Cheng SX; Dhar AD; Klaus SN
    Clin Exp Dermatol; 2004 Sep; 29(5):547-8. PubMed ID: 15347347
    [No Abstract]   [Full Text] [Related]  

  • 2. Dermatological side effects of hepatitis C and its treatment: patient management in the era of direct-acting antivirals.
    Cacoub P; Bourlière M; Lübbe J; Dupin N; Buggisch P; Dusheiko G; Hézode C; Picard O; Pujol R; Segaert S; Thio B; Roujeau JC
    J Hepatol; 2012 Feb; 56(2):455-63. PubMed ID: 21884670
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Editorial comment: erythropoietin for treatment-related anemia in persons with hepatitis C--questions remain.
    Yachimski P; Chung RT
    AIDS Read; 2004 Oct; 14(10):568-9. PubMed ID: 15510393
    [No Abstract]   [Full Text] [Related]  

  • 4. [Peripheral neuropathy during a second cycle of treatment with high doses of interferon-alpha in a patient with hepatitis C, and a review of the literature].
    Téllez-Zenteno JF; Negrete-Pulido O; Nuñez M; Estañol-Vidal B; García-Ramos G
    Rev Neurol; 2002 Oct 1-15; 35(7):644-6. PubMed ID: 12389150
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interferon-alpha associated arthritis.
    Chung A; Older SA
    J Rheumatol; 1997 Sep; 24(9):1844-5. PubMed ID: 9292816
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Guillain-Barré syndrome during treatment with interferon alpha for hepatitis B.
    Boz C; Ozmenoglu M; Aktoz G; Velioglu S; Alioglu Z
    J Clin Neurosci; 2004 Jun; 11(5):523-5. PubMed ID: 15177399
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Sarcoid granulomas in facial cosmetic filler material: induction by interferon-α and ribavirin in a patient with hepatitis C].
    López-Pestaña A; Tuneu A; Lobo C; Zubizarreta J
    Actas Dermosifiliogr; 2011 Nov; 102(9):746-7. PubMed ID: 21640959
    [No Abstract]   [Full Text] [Related]  

  • 8. Hepatitis C, interferon alfa, and depression.
    Zdilar D; Franco-Bronson K; Buchler N; Locala JA; Younossi ZM
    Hepatology; 2000 Jun; 31(6):1207-11. PubMed ID: 10827143
    [No Abstract]   [Full Text] [Related]  

  • 9. [IFN-alpha-induced psoriatic arthritis and HCV-related liver cirrhosis. Therapeutic options and patient's opinion].
    Cauli A; Porru G; Vacca A; Mameli A; Ibba V; Mura V; Piga M; Mathieu A
    Reumatismo; 2008; 60(1):57-60. PubMed ID: 18432326
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interferon-induced mania.
    Malik AR; Ravasia S
    Can J Psychiatry; 2004 Dec; 49(12):867-8. PubMed ID: 15679218
    [No Abstract]   [Full Text] [Related]  

  • 11. An unusual axonal polyneuropathy induced by low-dose interferon alfa-2a.
    Rutkove SB
    Arch Neurol; 1997 Jul; 54(7):907-8. PubMed ID: 9236581
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Hepatitis C with fatigue and polyneuropathy].
    Thimme R
    Dtsch Med Wochenschr; 2010 Dec; 135(48):2428. PubMed ID: 21108160
    [No Abstract]   [Full Text] [Related]  

  • 13. Cutaneous ulceration induced by interferon alfa.
    Gallelli L; Guadagnino V; Caroleo B; Marigliano N; De Sarro G
    Ann Pharmacother; 2004 Jan; 38(1):173-4. PubMed ID: 14742818
    [No Abstract]   [Full Text] [Related]  

  • 14. Chronic inflammatory demyelinating polyneuropathy during treatment with interferon-alpha.
    Marzo ME; Tintoré M; Fabregues O; Montalbán X; Codina A
    J Neurol Neurosurg Psychiatry; 1998 Oct; 65(4):604. PubMed ID: 9771799
    [No Abstract]   [Full Text] [Related]  

  • 15. [Gingival insensitivity and blood protein disorder in a peripheral neuropathy called primary infectious polyneuritis].
    Nayrac P; Graux P; Lorrain A; Gondolo G
    Lille Med; 1966 Apr; 11(4):466-7. PubMed ID: 5932306
    [No Abstract]   [Full Text] [Related]  

  • 16. Loss of smell (anosmia) and taste (ageusia) in a patient treated with pegylated interferon alfa and ribavirin.
    Mayet AY
    Curr Ther Res Clin Exp; 2007 Jul; 68(4):271-7. PubMed ID: 24683217
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pericarditis and chronic inflammatory demyelinating polyneuropathy during therapy with pegylated interferon alfa-2a for chronic hepatitis C.
    Nishio K; Konndo T; Okada S; Enchi M
    World J Hepatol; 2010 Sep; 2(9):358-61. PubMed ID: 21161021
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acute inflammatory demyelinating polyneuropathy associated with pegylated interferon alpha 2a therapy for chronic hepatitis C virus infection.
    Khiani V; Kelly T; Shibli A; Jensen D; Mohanty SR
    World J Gastroenterol; 2008 Jan; 14(2):318-21. PubMed ID: 18186575
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The peripheral polyneuropathy in patients with chronic HCV infection treated peginterferon alfa with ribavirin].
    Lapiński TW; Nowacka B; Michalewicz M
    Pol Merkur Lekarski; 2005 Apr; 18(106):431-2. PubMed ID: 16161928
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.